Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 713 (USA) (Dr. Kowalski)
· consented 2013-05-27
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild ABDOMINAL PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-30 (study day 4.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate ABDOMINAL PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-30 (study day 4.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-02 (study day 7.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild DIZZINESS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-31 (study day 158.0); relationship: POSSIBLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.